Ronald Reagan UCLA Medical Center is a hospital located on the campus of the University of California, Los Angeles, in Westwood, Los Angeles, California, United States. It is currently ranked the 5th best hospital in the United States by U.S. News & World Report, and 2nd best in California and the West Coast.

During the past decade, The Regents of the University of California - Los Angeles (UCLA Pediatrics) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Regents of the University of California - Los Angeles (UCLA Pediatrics)" #1 collaborator was "UCB Pharma" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The Regents of the University of California - Los Angeles (UCLA Pediatrics)" are "Acute Lymphoblastic Leukemia" (1 trials), "Neoplasm Metastasis" (1 trials), "Refractory Multiple Myeloma" (1 trials), "Refractory Solid Tumor" (1 trials) and "Relapsed Multiple Myeloma" (1 trials). Many other conditions were trialed in "The Regents of the University of California - Los Angeles (UCLA Pediatrics)" in a lesser frequency.

Most popular intervention types in "The Regents of the University of California - Los Angeles (UCLA Pediatrics)" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (2 trials), "Irinotecan" (2 trials), "Temozolomide" (2 trials), "Dinutuximab" (1 trials) and "FLAG (fludarabine, cytarabine and G-CSF)" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Regents of the University of California - Los Angeles (UCLA Pediatrics)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "The Regents of the University of California - Los Angeles (UCLA Pediatrics)". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in The Regents of the University of California - Los Angeles (UCLA Pediatrics), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Regents of the University of California - Los Angeles (UCLA Pediatrics), 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".